Evidence map›Paper›PMID 40202687›Full record

ArticleInfection2025

Caseload, clinical spectrum and economic burden of infectious diseases in patients discharged from hospitals in Germany.

H Stocker, F Kron, P Hartmann, K de With, M Addo, M Vehreschild, G Fätkenheuer, B Salzberger, L E Sander, Jan Rupp

Abstract read
In one paragraph

Article in Infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

H StockerDepartment of Infectious Diseases, St. Joseph Hospital, Berlin-Tempelhof, Berlin, Germany.
F KronDepartment I of Internal Medicine, University Hospital of Cologne, University of Cologne, Cologne, Germany.
P HartmannDepartment of Infectious Diseases, Hospital of the Cellites - St. Vinzenz, Cologne, Germany.
K de WithInstitute of Infectious Diseases, University Hospital Carl Gustav Carus at the Technical University, Dresden, Germany.
M AddoGerman Center for Infection Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
M VehreschildDepartment 2 of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.
G FätkenheuerDepartment I of Internal Medicine, Division of Infectious Diseases, Medical Faculty, University Hospital of Cologne, University of Cologne, Cologne, Germany.
B SalzbergerDepartment of Infection Prevention and Infectious Diseases, University Hospital Regensburg, Regensburg, Germany.
L E SanderDepartment of Infectious Diseases, Respiratory and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Jan RuppInstitute of Medical Microbiology, University Hospital Schleswig-Holstein/ Campus Lübeck and Kiel, Kiel, Germany. jan.rupp@uksh.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOver the last century infectious diseases have been kept under control in industrialized countries thanks to advances in hygiene, prevention and antimicrobial treatments. However, the emergence of HIV, the COVID-19 pandemic, and the rise of resistant bacteria exemplify that infectious diseases continue to pose a global threat. A comprehensive understanding of the caseload, spectrum of infectious diseases and the economic impact they pose is required to develop strategies for managing infectious diseases in a resilient healthcare system.

objectives(i) to determine the proportion of adult patients discharged from German hospitals with primary diagnoses classified as an infectious disease, (ii) to describe the clinical spectrum of these diagnoses, case characteristics, and hospital settings, and (iii) to estimate the total economic burden that these cases contribute to the in-patient sector of the healthcare system.

methodsA retrospective case-control study was performed using publicly available data on ICD10 codes assigned as primary diagnoses, case characteristics, treatment settings, and cost weights from all patients discharged from German hospitals in 2022.

results1,728,824 adult patients (12% of all adult patients) were discharged with a primary diagnosis classified as an infectious disease. They were assigned 912 individual ICD10 codes. The 15 and 79 most frequently used codes comprised 40% (top 40% ID population) and 80% (top 80% ID population) of all infectious disease cases, respectively. In the top 80% ID population, patients were older, were more likely to be male, and had higher complexity and comorbidity levels than the reference population, which consisted of all adult patients minus the patients in the top 80% ID population. The mean length of stay of patients forming the top 80% ID population was 8.0 days vs. 6.1 days in the reference population. The median (IQR) cost weight was 0.663 (0.544-1.030) translating into €2,541 per case.

conclusionsIn Germany, patients with infectious diseases constitute a significant proportion of all inpatients, with a broad spectrum of conditions. These patients are generally older, more severely ill, and require longer hospital stays than those without a primary infectious disease diagnosis, contributing substantially to the overall economic burden on the healthcare system.

Indexed as

Communicable DiseasesCost of IllnessPatient DischargeAdolescentAdultAgedAged, 80 and overCase-Control StudiesCOVID-19FemaleGermanyHumansMaleMiddle AgedRetrospective StudiesYoung AdultAntimicrobial resistanceCost and reimbursementHealthcare system and specializationHealth economic analysisHospitalization and caseloadInfectious diseases

Identifiers

PMID40202687
PMCPMC12460425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.